Why is Balaxi Pharma falling/rising?

As of 03-Jul, Balaxi Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 48.87, which reflects a decrease of Rs 0.2 or 0.41%. The stock is trading close to its 52-week low, just 0.7% away from Rs 48.53. It is also underperforming against its moving averages, trading lower than the 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has dropped by 2.22%, and its year-to-date performance shows a significant decline of 32.42%. While the company has strong long-term fundamentals, including a high average return on equity of 30.97% and healthy growth in net sales, it has faced challenges with a substantial year-over-year return of -59.69% and a recent fall in profits by 31.3%.
In the broader market context, Balaxi Pharmaceuticals' short-term performance has been notably worse than the benchmark Sensex, which has seen a slight decline of 0.56% over the same week. The stock's liquidity remains adequate for trading, but there has been a 12.31% drop in delivery volume, indicating falling investor participation. Additionally, the company has reported flat results in its latest quarter, with a 12.7% decrease in profit after tax, contributing to a perception of below-par performance both in the near and long term. This combination of factors suggests that investor sentiment is currently negative, leading to the stock's decline.